Clinical Trial Update: Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of enzastaurin in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has completed; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-11-21